Bellerophon Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Cash & Equivalents	4.38	6.92	24.74	47.56	9.87	16.65
Cash & Short-Term Investments	4.38	6.92	24.74	47.56	9.87	16.65
Cash Growth	-61.28%	-72.01%	-47.99%	381.64%	-40.68%	-47.69%
Prepaid Expenses	0.49	0.23	0.62	0.42	0.41	0.65
Restricted Cash	0.11	0.41	0.1	0.1	0.1	0.1
Total Current Assets	4.98	7.56	25.46	48.08	10.38	17.4
Property, Plant & Equipment	-	0.19	0.93	1.67	2.43	0.66
Other Long-Term Assets	-	0.19	0.49	0.49	0.3	0.3
Total Assets	4.98	7.94	26.88	50.24	13.11	18.36
Accounts Payable	0.61	1.23	1.19	3.73	3.11	2.76
Accrued Expenses	0.64	3.97	3.11	6	3.82	4.78
Current Portion of Leases	-	0.2	0.75	0.7	0.66	-
Total Current Liabilities	1.26	5.4	5.05	10.43	7.58	7.54
Long-Term Leases	-	-	0.2	0.96	1.66	-
Other Long-Term Liabilities	-	-	0	0.6	0.27	6.97
Total Liabilities	1.26	5.4	5.26	11.99	9.52	14.5
Common Stock	0.12	0.1	0.1	0.1	0.05	0.04
Additional Paid-In Capital	259.92	254.52	253.77	252.65	193.31	180.31
Retained Earnings	-256.32	-252.08	-232.25	-214.49	-189.76	-176.5
Shareholders' Equity	3.72	2.53	21.62	38.25	3.59	3.86
Total Liabilities & Equity	4.98	7.94	26.88	50.24	13.11	18.36
Total Debt	-	0.2	0.96	1.66	2.32	-
Net Cash (Debt)	4.38	6.72	23.78	45.9	7.56	16.65
Net Cash Growth	-59.88%	-71.74%	-48.19%	507.34%	-54.60%	-47.69%
Net Cash Per Share	0.39	0.70	2.50	5.89	1.68	3.84
Filing Date Shares Outstanding	12.23	10.45	9.55	9.49	6.13	4.59
Total Common Shares Outstanding	12.23	9.65	9.55	9.49	4.58	3.91
Working Capital	3.72	2.16	20.41	37.65	2.8	9.86
Book Value Per Share	0.30	0.26	2.26	4.03	0.78	0.99
Tangible Book Value	3.72	2.53	21.62	38.25	3.59	3.86
Tangible Book Value Per Share	0.30	0.26	2.26	4.03	0.78	0.99
Machinery	-	2.32	2.32	2.32	2.32	2.32
Leasehold Improvements	-	0.2	0.2	0.2	0.2	0.2

Source: S&P Global Market Intelligence. Standard template. Financial Sources.